Pfizer takes a surprising hit to its rare disease plan as FDA snubs new growth deficiency med
Pfizer takes a surprising hit to its rare disease plan [...]
Poland’s largest pharma scouts for joint bidder in potential $4B buyout of former Sanofi generics unit: Reuters
Poland’s largest pharma scouts for joint bidder in potential $4B [...]
Fierce JPM Week: Bristol Myers’ next-gen autoimmune med not just another JAK drug, exec says
Fierce JPM Week: Bristol Myers’ next-gen autoimmune med not just another [...]
It’s a matter of national security: Sanofi doesn’t want new high-rise neighbors watching its Toronto plant
It’s a matter of national security: Sanofi doesn’t want new [...]
GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand
GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand [...]
You say Trintellix, I say Brintellix: Why a drug name in the US won’t always translate across the pond
You say Trintellix, I say Brintellix: Why a drug name [...]
Fierce Pharma Asia—Lilly-Abbisko cardiometabolic pact; Daiichi Sankyo asset sale; Eisai’s next Alzheimer’s prospect
Fierce Pharma Asia—Lilly-Abbisko cardiometabolic pact; Daiichi Sankyo asset sale; Eisai’s [...]
Ogilvy Health’s new creative chief Hessel reflects on pharma’s pandemic opportunities
Ogilvy Health’s new creative chief Hessel reflects on pharma’s pandemic [...]
Blueprint promotes two more execs to C-suite as it looks to realize Ayvakit’s potential
Blueprint promotes two more execs to C-suite as it looks [...]
Viatris yanks one batch of diabetes med Semglee because of missing label risks
Viatris yanks one batch of diabetes med Semglee because of [...]